WPI 3170 (Alendronate sodium 10 mg)
Pill imprint WPI 3170 has been identified as Alendronate sodium 10 mg.
Alendronate is used in the treatment of osteoporosis; prevention of osteoporosis; paget's disease; aseptic necrosis and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Alendronate 10 mg is not subject to the Controlled Substances Act.
See also related documents.